RoslinCT, a leading global cell therapy Contract Development and Manufacturing Organization, today announced a strategic partnership with BlueRock Therapeutics, a leader in stem cell therapeutic ...
Biomedical engineers at Duke University have used induced pluripotent stem cells (iPSCs) to grow specialized blood vessel ...
Blind People Offered Hope of Seeing Again After Stem Cell Breakthrough Remakes Retinal Blood Vessels
When injected into mice with retinal disease, the special retinal blood cells integrated into the damaged tissue to ...
DUBLIN--(BUSINESS WIRE)--The "Induced Pluripotent Stem Cells Market" report has been added to ResearchAndMarkets.com's offering. The Induced Pluripotent Stem Cells Market was valued at USD 3.4 billion ...
Scientists say lab-grown stem cells were used to restore retinal function in blind mice. The post Stem cell breakthrough ...
Southwest Research Institute (SwRI) has demonstrated a new application for its cell-expansion bioreactor to advance tissue engineering and cell-based therapies for treatment of injuries and diseases.
Pluristyx Inc., the leader in advanced induced pluripotent stem cell (iPSC) technologies, announces today the Initial Close of their Series A financing led by a global Fortune 500 company along with ...
United Therapeutics has paid $140 million to buy Thymmune Therapeutics for preclinical regenerative cell therapies focused on the thymus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results